KRAS and neoplasm: However, despite the loss of KRAS transcripts seen 2 weeks after the Dox was discontinued, these cells still showed elevated YB-1 protein levels that were similar to those evident in the tumours obtained from cells in which KRASG12D expression had been sustained (Fig. 4E).